Edit |   |
---|---|
Antigenic Specificity | Toxin B, Clostridium difficile (Bezlotoxumab biosimilar) |
Clone | Bezlotoxumab |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Clostridium Difficile Toxin B Recombinant Antibody. Bezlotoxumab, sold under the brand name Zinplava, is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infections. This drug, along with actoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School. |
Immunogen | n/a |
Other Names | Anti-Toxin B Recombinant Antibody, Research Grade Bezlotoxumab, Anti-Clostridium Difficile Toxin B Recombinant Antibody, MK-6072, CDB-1, MDX-1388, MK-3415A (combination of actoxumab and bezlotoxumab), formerly CDB 1, Antibody Drug Analogues, Monoclonal Antibody, YR1273, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1246264-45-8 |
Catalog # | YR1273 |
Price | please inquire |
Order / More Info | Toxin B, Clostridium difficile (Bezlotoxumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |